Skip to content

the effect of low free sugar diet in patients with polycystic ovary syndrome

The effect of low free sugar diet on anthropometric parameters, lipid profile and glycemic control in women with polycystic ovarian syndrome

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT20230615058489N1
Enrollment
74
Registered
2023-06-25
Start date
2023-07-06
Completion date
Unknown
Last updated
2023-06-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Polycystic Ovary syndrome. Polycystic ovarian syndrome

Interventions

Intervention 1: Intervention group: For 12 weeks, the low free sugar diet (less than 3% of calories are from free sugar) is provided along with the recommendations of a healthy diet and physical activ

Sponsors

Islamic Azad University
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 45 Years

Inclusion criteria

Inclusion criteria: willingness to participate in research Age 18-45 years BMI> 25 Having polycystic ovarian syndrom based on the diagnosis of gynecologist ( According to Rotterdom criteria) Less than 6 months have passed since diagnosis People who get more than 10% of their calories from free sugars Absence of other diseases and chronic and acute disorders of women such as uterine and ovarian cancers Not suffering from liver diseases, suffering from kidney failure and heart failure, suffering from infectious or inflammatory diseases, suffering from thyroid gland disorders, diabetes, types of cancer, hyperprolactinemia Not pregnant or breastfeeding Non-adherence to special diets or weight loss diets in the last three months Not using hormonal drugs, corticosteroids, omega-3 and spironolactone

Exclusion criteria

Exclusion criteria: Unwillingness to continue cooperation Failure to follow the intervention diet for more than 2 days Starting a new diet other than the nutritional recommendations provided in the control group pregnancy Changing the medication regimen, physical activity during the intervention period

Design outcomes

Primary

MeasureTime frame
Fasting Blood Glucose (FBG). Timepoint: Beggining and after 12 weeks. Method of measurement: Enzymatic method.;Serum insulin. Timepoint: Beggining and after 12 weeks. Method of measurement: ELISA.;HOMA-IR. Timepoint: Beggining and after 12 weeks. Method of measurement: Calculate.;QUICKI. Timepoint: Beggining and after 12 weeks. Method of measurement: calculate.;Serum triglycerides. Timepoint: Beggining and after 12 weeks. Method of measurement: Enzymatic Method.;Total serum cholesterol. Timepoint: Beggining and after 12 weeks. Method of measurement: Enzymatic Method.;Serum LDL-C. Timepoint: Beggining and after 12 weeks. Method of measurement: Enzymatic Method.;Serum HDL-C. Timepoint: Beginning and after 12 weeks. Method of measurement: Enzymatic Method.;Weight. Timepoint: Beginning and after 12 weeks. Method of measurement: Scales.;Body Mass Index. Timepoint: Beginning and after 12 weeks. Method of measurement: Calculate.;Waist to hip ratio. Timepoint: Beginning and after 12 weeks. Method of measurement: Calculate.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactAsal Ataie Jafari

Islamic Azad University

asal_ataie2003@yahoo.com+98 21 4486 5179

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Aug 5, 2026